NovaSterilis
PrivateLast Round
Grant
Feb 1, 2024
Total Funding Raised
$7.39M
Company Overview
NovaSterilis is a biotechnology company that develops and manufactures supercritical carbon dioxide (scCO2) sterilization and decellularization technology platforms for the regenerative medicine, medical device, and pharmaceutical industries.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Medical Devices, Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NovaSterilis Comparables
Compare NovaSterilis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Noxilizer | 83% | |
| Andersen Sterilizers, Inc. | 74% | |
| De Lama S.p.A. | 69% | |
NovaSterilis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2024 | ||||
| Grant | Sep 20, 2022 | ||||
| Grant | Jan 18, 2017 | ||||
| Grant | Feb 1, 2015 | ||||
| Grant | Sep 1, 2012 | ||||
Grant | Sep 15, 2011 |
NovaSterilis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Big Red Ventures | Seed |
| National Institutes of Health (NIH) | Grant |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Presenting at the 34th Annual Conference of the European Society for Biomaterials.
- Feb 1, 2024
$1.75M grant from National Institute of Allergy and Infectious Diseases.
NovaSterilis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NovaSterilis's valuation, stock price, and market status.